Torrent Pharmaceuticals
₹4,767.30Change from previous close: −0.68%Absolute change: −₹32.70
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ₹1.81T
- Enterprise value
- ₹1.83T
- P/E (trailing 12 months)
- 76.3
- Forward P/E
- 51.2
- Price/book
- 19.2
- Price/sales
- 11.5
- EV/EBITDA
- 38.1
- EV/revenue
- 11.7
Profitability and growth
- Gross margin
- 76.0%
- Operating margin
- 21.8%
- Net margin
- 13.9%
- Revenue growth (year over year)
- 54.8%
- Earnings growth (year over year)
- -8.2%
Financial health
- Total cash
- ₹23.55B
- Total debt
- ₹150.25B
- Debt/equity
- 0.85
Dividends
- Annual dividend per share
- ₹38.00
- Dividend yield
- 0.8%
- Payout ratio
- 60.7%
- Ex-dividend date
- May 29, 2026
Analysts and estimates
- Average price target
- ₹5,430.93
- Median price target
- ₹5,500.00
- High price target
- ₹6,194.00
- Low price target
- ₹4,670.00
- Analysts with a price target
- 28
- Forward EPS
- ₹93.15
- EPS estimate, current year
- ₹67.43
Shares and trading
- Beta
- 0.14
- Average volume
- 539.9K
- Shares outstanding
- 380.37M
- Float
- 130.66M
- Institutional ownership
- 19.5%
- Insider ownership
- 63.2%